{"disease":{"id":"tyrosinemia-type-ii","name":"tyrosinemia type ii"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT05910151","title":"Selective Screening of Children for Hereditary Metabolic Diseases by Tandem Mass Spectrometry in Kazakhstan","phase":"","overall_status":"UNKNOWN","enrollment_count":2250,"lead_sponsor_name":"West Kazakhstan Medical University","has_results":false},{"nct_id":"NCT04196959","title":"Evaluation of TYR Sphere","phase":"NA","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Vitaflo International, Ltd","has_results":false},{"nct_id":"NCT06298292","title":"Acceptability/Tolerance of Protein Substitutes in Tablet Form for the Dietary Management of Rare Aminoacidopathies","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":15,"lead_sponsor_name":"metaX Institut fuer Diatetik GmbH","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}